Photocure ASA
OSE:PHO

Watchlist Manager
Photocure ASA Logo
Photocure ASA
OSE:PHO
Watchlist
Price: 57.8 NOK 0.17%
Market Cap: 1.6B NOK

Photocure ASA
EPS (Diluted)

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Photocure ASA
EPS (Diluted) Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company EPS (Diluted) CAGR 3Y CAGR 5Y CAGR 10Y
Photocure ASA
OSE:PHO
EPS (Diluted)
kr0
CAGR 3-Years
46%
CAGR 5-Years
N/A
CAGR 10-Years
17%
V
Vistin Pharma ASA
OSE:VISTN
EPS (Diluted)
kr1
CAGR 3-Years
36%
CAGR 5-Years
-1%
CAGR 10-Years
N/A
N
Navamedic ASA
OSE:NAVA
EPS (Diluted)
kr0
CAGR 3-Years
21%
CAGR 5-Years
-51%
CAGR 10-Years
N/A
S
SoftOx Solutions AS
OSE:SOFTX
EPS (Diluted)
kr0
CAGR 3-Years
83%
CAGR 5-Years
59%
CAGR 10-Years
N/A

Photocure ASA
Glance View

Market Cap
1.6B NOK
Industry
Pharmaceuticals

Photocure ASA delivers transformative solutions to improve the lives of bladder cancer patients. The company is headquartered in Oslo, Oslo. The company went IPO on 2000-05-29. The company operates in the field of photodynamic diagnosis, cosmetics and treatment of acne, bladder cancer, colon cancer, as well as human papilloma virus (HPV) and precancerous lesions of the cervix. The Company’s activities comprise research, development and commercialization of pipeline projects within two segments: Cancer and Dermatology. Its brand portfolio includes: Hexvix and Cysview, for detection and management of bladder cancer; Visonac, for acne treatment; Cevira, used in HPV and precancerous lesions of the cervix treatment; and Lumacan, applied in colorectal cancer treatment. Furthermore, It owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. The firm is a parent of a wholly owned entity, Photocure Inc.

PHO Intrinsic Value
72.89 NOK
Undervaluation 21%
Intrinsic Value
Price

See Also

What is Photocure ASA's EPS (Diluted)?
EPS (Diluted)
-0.2 NOK

Based on the financial report for Dec 31, 2024, Photocure ASA's EPS (Diluted) amounts to -0.2 NOK.

What is Photocure ASA's EPS (Diluted) growth rate?
EPS (Diluted) CAGR 10Y
17%

The average annual EPS (Diluted) growth rates for Photocure ASA have been 46% over the past three years , and 17% over the past ten years .

Back to Top